Avoiding duodenal endoscopic biopsies in celiac disease: Are we going forward or looking to the past?

Digestive and Liver Disease

Volumn 42, Issue 2, 2010, Pages 154-

  Elli, L ^a   Bonura, A ^a   Bardella, M T ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELIAC DISEASE; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DUODENOSCOPY; ENDOSCOPIC BIOPSY; GENETIC POLYMORPHISM; GIARDIASIS; HISTOLOGY; HUMAN; INTESTINE VILLUS ATROPHY; LETTER; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT; DUODENUM; GASTROINTESTINAL ENDOSCOPY; INTESTINE MUCOSA; MICROVILLUS; NOTE; PATHOLOGY; DUODENUM BIOPSY; ENTERITIS; HISTOPATHOLOGY; INTERMETHOD COMPARISON; LYMPHOCYTE COUNT; STATISTICAL ANALYSIS;

CELIAC DISEASE; DUODENUM; ENDOSCOPY, GASTROINTESTINAL; HUMANS; INTESTINAL MUCOSA; MICROVILLI; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 73749088463     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.05.011     Document Type: Letter

References (5)

1. Masci E, Mangiavillano B, Barera G, et al. Optical coherence tomography in pediatric patients: a feasible technique for diagnosing celiac disease in children with villous atrophy. Dig Liver Dis; in press.
2. Setty M., Hormaza L., and Guandalini S. Celiac disease: risk assessment, diagnosis, and monitoring. Mol Diagn Ther 12 (2008) 289-298
3. Di Tola M., Sabbatella L., Anania M.C., et al. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med 42 (2004) 1092-1097
4. Krauss N., and Schuppan D. Monitoring nonresponsive patients who have celiac disease. Gastrointest Endosc Clin N Am 16 (2006) 317-327
5. Rutgeerts P., Vermeire S., and Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology 136 (2009) 1182-1197